Measurements of other key cytokines involved in T effector functions during viral infections, such as tumor necrosis factor alpha and granzyme B,24 might further validate the efficacy of the T-cell response observed in DS after primary SARS-CoV-2 vaccination. This evidence concerns the gene GZMB and viral infectious disease.